![ResearchPod artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts123/v4/5f/9b/c2/5f9bc25a-f372-8d1e-dbba-0c467fbd8bf8/mza_3639348859910855366.jpg/100x100bb.jpg)
Can a free-to-choose medicine pathway improve patient treatment?
ResearchPod
English - April 08, 2024 10:00 - 13 minutes - 9.22 MBScience Technology science research outreach education stem learning academic technology impact scicomm Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Scam Alert! Raising Employee Awareness of CEO Fraud Attacks
The process of obtaining FDA approval for a new drug costs an estimated $1.8 billion and can take up to 15 years. What’s more, only a small percentage of drugs that undergo human clinical trials are approved.
To address this, Bartley J Madden, Research Fellow at the Madden Center for Value Creation at Florida Atlantic University, USA, has developed a free to choose medicine (FTCM) model that is currently being considered by US Congress.
Read more in Research outreach
Read the original research: econjwatch.org/science-on-fda-liberalization